Your 90-Day AR Analysis is complimentary - See your true collection gap.
Ambulatory Surgical Centers

Are Facility Fees the Biggest ASC Revenue Leak?

Published Date - May 29, 2026 Modified Date - Oct 29, 2026 12 min read
Are Facility Fees the Biggest ASC Revenue Leak?
Home » Ambulatory Surgical Centers » Are Facility Fees the Biggest ASC Revenue Leak?

Yes. Facility fee undercoding is the single largest revenue leak in most ASCs. In fact, it costs $280,000–$480,000 per facility every 12 months in avoidable loss. However, no denial ever triggers a review.

The reason it stays invisible is structural. First, ASC billing teams apply physician billing logic to facility fee claims. They also misassign CMS payment groups on high-acuity procedures and miss device pass-through HCPCS C-codes. In addition, they undermanage unlisted procedure code submissions. As a result, clean claims pay consistently below allowable rates. So the revenue gap shows up as margin compression, not as a denial queue anyone is working.

For a deeper look at broader ASC revenue cycle issues, see Why Your ASC Billing Is Losing Revenue. It maps the billing failures MBC uncovers across ASC clients, from multiple procedure coding errors to prior authorization failures. Still, facility fee undercollection is the root of the ASC revenue leak most practices never isolate.

Key Takeaways

  • Facility fee undercoding generates significant revenue loss of $280,000–$480,000 annually for ASCs.
  • ASC billing teams often apply incorrect physician billing logic, causing systematic facility fee undercollection.
  • Three main issues compress ASC revenue: CMS payment group misassignment, device pass-through underbilling, and unlisted procedure code undermanagement.
  • As site-neutral payment policies expand, ASCs must adopt yield-based revenue management to recover lost revenue.
  • MBC’s Revenue Integrity Framework identifies critical billing errors and offers a structured recovery roadmap for ASCs.

The Physician Billing Problem Behind Your ASC Revenue Leak

ASC facility billing and physician billing are not one system. Instead, they are two independent reimbursement tracks. Each covers different cost components of the same procedure.

The surgeon submits a professional fee claim under their NPI. Then Medicare pays it under the Physician Fee Schedule, based on RVU values. Meanwhile, the ASC submits a separate facility fee claim for the same procedure. CMS pays it at the ASC Payment System rate for the procedure’s payment group, not the RVU value. Because these claims are independent, they need different billing logic, modifier structures, and documentation standards.

Billing Element Physician Billing ASC Facility Billing
Payment Basis RVU-based fee schedule CMS ASC payment group
Device Reimbursement Not applicable HCPCS C-codes (pass-through)
Unlisted Procedure Handling Standard documentation AMA crosswalk + comparable pricing required
Quality Reporting MIPS ASC Quality Reporting (ASCQR) Program
MAC Jurisdiction Impact Minimal rate variation Significant — group assignments vary by MAC

Applying physician billing workflows to ASC facility claims is the foundational error. It creates a systematic ASC revenue leak on facility fee claims. For example, some teams treat the facility claim as a copy of the surgeon’s claim. They use the same CPT, logic, and documentation. When they do, they skip payment group verification, modifier structure, and device pass-through submission. Yet these steps determine the facility’s actual reimbursement.

MBC’s Revenue Integrity Framework identifies this error as the main driver of payer variance in facility fee payments. Moreover, generic RCM vendors without ASC-specific infrastructure miss it most often.

How Medicare Pays the ASC Facility Fee

Medicare-certified ASCs submit facility fee claims on the CMS-1500 or its electronic 837P equivalent. They use the facility’s own NPI, as set out in Chapter 14 of the Medicare Claims Processing Manual. CMS also gives each covered procedure a payment indicator that tells the MAC how to price the line. For instance, the MAC may pay the line at the standard ASC rate or package it into another service. Alternatively, it may pay the line separately as a device or drug, or reduce it under the multiple procedure discount.

This is where physician-billing habits do the most damage. A professional fee biller treats the CPT code as the payment driver. On the ASC facility claim, however, the payment indicator, modifier sequence, and line-level device codes drive reimbursement. So an error in any of them produces a clean claim that pays less than the facility earned. Worse, no denial flags it.


Three Structural Failures Behind the ASC Revenue Leak

Failure 1: CMS Payment Group Misassignment

CMS assigns every covered ASC procedure to a payment group, and that group sets the facility rate. Complex procedures carry higher payment group assignments. These include spinal injections (CPT 27096, 62323), pain management interventions, and multi-level nerve blocks. To capture the correct rate, they need specific HCPCS modifiers and operative documentation.

Some ASC billing teams submit standard CPT codes without verifying the payment group. As a result, they routinely receive 20%–35% less than the allowable facility rate. CGS Administrators and Palmetto GBA are the Medicare Administrative Contractors (MACs) for most ASC volume in the Southeast and Midwest. Under both, payment group verification is a mandatory pre-submission step. However, most billing teams skip it entirely.

CMS publishes the payment indicator and national rate for every covered surgical procedure in the ASC payment rates addenda. Addendum AA covers surgical procedures, and Addendum BB covers ancillary services. CMS updates both quarterly and then adjusts the national rates for local wages. So compare paid amounts on your remittance advice against the current addendum rate for your locality. This is the most direct way to confirm a high-acuity claim paid at the correct ASC facility fee level.

Consider the size of this ASC revenue leak. Take a facility that bills 40 complex procedures per month at 25% below the correct group rate. That facility absorbs a $280,000–$840,000 shortfall every 12 months. Yet it generates no denial, no appeal trigger, and no compliance flag. The facility simply never collects the money.

Failure 2: Device Pass-Through Underbilling

For example, high-cost devices include implantable spinal cord stimulators, pain pumps, and drug-eluting stents. For these procedures, the facility fee alone does not capture device cost. Instead, CMS’s pass-through payment mechanism requires specific HCPCS C-codes on the facility claim, alongside the procedure code.

Some ASC billing teams don’t know which devices have active pass-through status. As a result, they absorb device costs entirely — a $4,200–$18,000 per-case ASC revenue leak. Pass-through status also expires, typically after two to three years. New devices qualify and existing pass-throughs expire on a rolling basis. Therefore, teams must monitor status actively.

The operational failure is not a lack of awareness about pass-through payments. Rather, ASCs have no active system that alerts the billing team when a routine device gains or loses pass-through status. This is a technological efficiency gap, not a knowledge gap.

CMS maintains the current list of pass-through device categories and updates it quarterly. On the ASC side, separately payable pass-through devices carry payment indicator J7. In contrast, device-intensive procedures carry J8. This decides whether CMS pays the device separately or builds it into a higher procedure rate. So reconcile your device log against each quarterly update. Otherwise, your team can’t reliably know which HCPCS C-codes are currently payable.

Failure 3: Unlisted Procedure Code Undermanagement

Some ASC procedures have no specific CPT code. Instead, the ASC bills them as CPT 17999, 27299, or another unlisted code. In these cases, reimbursement depends entirely on the documentation sent with the claim. Generic operative notes often lack AMA crosswalk documentation, comparable procedure pricing, and payer-specific submission details. Consequently, unlisted code payments average 40%–60% below comparable listed procedure rates.

Take a facility that performs eight unlisted procedure cases per month. That is an ASC revenue leak of $28,000–$64,000 per month in uncaptured, negotiable reimbursement. In other words, the payer didn’t deny the claim. Instead, the documentation gave the payer no basis to pay at the correct rate.


ASC Revenue Leak Self-Audit: Where Does Your Facility Stand?

Before drawing any conclusions about your facility fee performance, pull these four data points from your last 60 days of remittance advice:

Question What to Pull Red Flag Revenue at Stake
Are complex procedures billed at correct CMS payment group? High-acuity claims — spinal injections, nerve blocks Reimbursement 20%+ below expected group rate $280–$840 per case
Are device-intensive cases submitting HCPCS C-codes? Cases involving implantables, stimulators, drug-eluting devices Any device case without a C-code on the facility claim $4,200–$18,000 per case
Are unlisted procedure codes supported by AMA crosswalk docs? CPT 17999, 27299, and other unlisted codes Generic operative notes without comparable procedure pricing 40%–60% below comparable rate
Is facility fee billed separately from surgeon professional fee? Split claim review — facility NPI vs. surgeon NPI Single claim combining both $600–$1,800 per case

Any single red flag in this audit confirms an ASC revenue leak. When all four appear together, the facility fits a familiar pattern. In fact, MBC’s denial root-cause engineering process finds this profile in most ASC facilities entering a Revenue Diagnostic.


Site-Neutral Payment Expansion Is Widening the ASC Revenue Leak

CMS’s site-neutral payment policy equalizes reimbursement between hospital outpatient departments and ASCs for select procedures. As a result, it compresses the payment differential that once made ASCs financially viable against hospitals. Meanwhile, the per-case margin ASCs relied on is narrowing from both directions. Reimbursement rates are declining, while billing failures still absorb 20%–35% of what remains.

The operational response is a shift from volume-based billing to yield-based revenue management. In other words, ASCs maximize net realized revenue on every case. They stop relying on case volume growth to offset per-case margin compression.

Yield EBITDA is net realized revenue per surgical case after payer adjustments, device costs, and facility overhead. Today, PE-backed ASC groups and multi-OR facilities are adopting it as their primary performance metric. Some ASC billing infrastructure cannot produce Yield EBITDA reporting by case type, payer, and surgeon. Consequently, that infrastructure is blind to where the facility creates margin and where it loses it. For this reason, MBC’s fee structure centers on this output. It ties fees to net realized revenue recovery, not claim volume.

Payer variance detection across your commercial contracts is the companion metric. It identifies which payers systematically pay below contracted rates on facility fee claims. Then it builds the appeal infrastructure to recover what payers owe before the filing window closes.

What the CY 2026 OPPS/ASC Final Rule Changes for Facility Fee Billing

Under the CY 2026 OPPS/ASC final rule, CMS finalized a 2.6% update to ASC payment rates. This update applies to facilities that meet quality reporting requirements. It reflects a 3.3% market basket increase minus a 0.7-point productivity adjustment. However, ASCs that fail to report under the ASC Quality Reporting (ASCQR) Program lose another 2 percentage points. That penalty compounds across every facility fee claim the ASC submits that year.

The same rule added 289 procedures to the ASC Covered Procedures List. It also began a three-year phase-out of the inpatient-only list. As part of that, it moved another 271 codes from that list to the ASC CPL. In addition, CMS extended site-neutral payment to drug administration services at excepted off-campus hospital departments. So more procedures are migrating into ASCs. But every newly covered procedure arrives with its own payment indicator, device rules, and documentation requirements. Facilities that add these cases without updating billing logic simply scale their existing ASC revenue leak.


How MBC’s Revenue Integrity Framework Finds Your ASC Revenue Leak

MBC’s Complimentary 90-Day AR Diagnostic for ASC facilities runs four parallel reviews that generic RCM vendors do not perform:

First, it verifies payment group assignments against operative documentation for every high-acuity procedure in the audit period. Second, it confirms active pass-through status for all billed devices. A gap analysis then flags device cases with missing C-codes. Third, it audits unlisted procedure code submissions against payer-specific documentation rules and AMA crosswalk standards. Finally, payer variance detection runs across the full commercial contract portfolio. It identifies systematic underpayment patterns by payer and procedure type.

The output is a quantified revenue recovery roadmap, organised by case type, payer, and failure category. As a result, the ASC administrator and CFO get a facility-specific action plan with dollar-value recovery targets. That is far more useful than a generic billing review summary.

Request a Revenue Diagnostic to find exactly where your ASC revenue leak sits. You will see which facility fee claims pay below allowable rates. You’ll also see what MBC’s Enterprise Revenue Integrity infrastructure recovers within the first 90 days.


ASC Revenue Leak: Frequently Asked Questions

What is an ASC facility fee and what does it cover?

An ASC facility fee is the payment an ambulatory surgery center receives for the facility resources used during a procedure — operating room time, nursing and clinical staff, supplies, routine drugs, and recovery care. It is billed separately from the surgeon’s professional fee and, for Medicare, is paid under the ASC Payment System, with rates updated each year in the CMS OPPS/ASC final rule.

What is the difference between ASC facility fee billing and physician billing for the same procedure?

The surgeon submits a professional fee claim under their NPI using standard CPT codes reimbursed at the Medicare Physician Fee Schedule. The ASC submits a separate facility fee claim for the same procedure reimbursed at the CMS ASC Payment System rate — determined by the procedure’s assigned payment group, not the RVU value. The two claims are independent, cover different cost components, and require different billing logic. Applying physician billing workflows to ASC facility claims is the foundational error producing systematic facility fee undercollection across most ASC billing operations.

How do CMS pass-through payments work for ASC device costs?

CMS grants temporary pass-through payment status to high-cost devices, drugs, and biologics used in ASC procedures — allowing the ASC to bill device cost separately from the facility fee using specific HCPCS C-codes. Pass-through status is time-limited, typically two to three years, and must be actively monitored because new devices qualify and existing pass-throughs expire on a rolling basis. ASCs missing active pass-through status for devices they regularly use absorb full device costs internally — a revenue gap that appears as declining margins rather than denied claims.

Which claim form does an ASC use to bill Medicare facility fees?

Medicare-certified ASCs bill facility fees on the CMS-1500 form (or its electronic 837P equivalent) under the ASC’s own NPI — not the UB-04 used by hospital outpatient departments. Commercial payers may require a UB-04 depending on the contract, so verify payer-specific claim form rules before submission to avoid rejections.

How does site-neutral payment expansion affect ASC facility fee strategy?

Site-neutral payment policy compresses the reimbursement differential between ASCs and hospital outpatient departments on select procedures — reducing the per-case margin advantage that historically made ASC operations financially competitive. As site-neutral expansion continues, ASCs must shift from volume-based billing to yield-based revenue management: maximizing net realized revenue per case through correct payment group assignment, device pass-through capture, and commercial payer variance recovery.

Related Posts

888-357-3226